Italia markets closed

Zimmer Biomet Holdings, Inc. (ZBH)

NYSE - NYSE Prezzo differito. Valuta in USD.
Aggiungi a portafoglio
171,88+0,12 (+0,07%)
Alla chiusura: 4:02PM EDT

Zimmer Biomet Holdings, Inc.

345 East Main Street
Warsaw, IN 46580
United States
574 267 6131

SettoreMedical Devices
Impiegati a tempo pieno20.000

Figure dirigenziali chiave

NomeTitoloRetribuzioneEsercitateAnno di nascita
Mr. Bryan C. HansonPres, CEO & Director3,03MN/D1967
Mr. Suketu P. UpadhyayExec. VP & CFO1,34MN/D1969
Mr. Ivan TornosGroup Pres of Global, The Americas & EMEA Region and COO1,49MN/D1976
Mr. Sang YiGroup Pres of Asia Pacific1,22MN/D1962
Ms. Carrie A. Nichol CPAVP, Controller & Chief Accounting OfficerN/DN/D1980
Mr. Zeeshan TariqVP & Chief Information OfficerN/DN/DN/D
Ms. Keri P. MattoxSr. VP of Investor Relations & Chief Communications OfficerN/DN/DN/D
Mr. Chad F. PhippsSr. VP, Gen. Counsel & Sec.N/DN/D1972
Ms. Angela MainSr. VP, Global Chief Compliance Officer & Associate Gen. Counsel of Asia PacificN/DN/DN/D
Ms. Lori WinklerChief HR OfficerN/DN/DN/D
Gli importi risalgono al giorno 31 dicembre 2020 e i valori di compensazione riguardano l'anno fiscale che si chiude a tale data. La retribuzione include salari, bonus ecc. "Esercitate" è il valore delle opzioni esercitate durante l'anno fiscale. Valuta in USD.


Zimmer Biomet Holdings, Inc., together with its subsidiaries, designs, manufactures, and markets musculoskeletal healthcare products and solutions in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company provides orthopaedic reconstructive products, such as knee and hip replacement products; S.E.T. products, including sports medicine, biologics, foot and ankle, extremities, and trauma products; spine products comprising medical devices and surgical instruments; and face and skull reconstruction products, as well as products that fixate and stabilize the bones of the chest to facilitate healing or reconstruction after open heart surgery, trauma, or for deformities of the chest. It also offers dental products that include dental reconstructive implants, and dental prosthetic and regenerative products, as well as surgical, bone cement, and office-based technology products. The company's products and solutions are used to treat patients suffering from disorders of, or injuries to, bones, joints, or supporting soft tissues. It serves orthopedic surgeons, neurosurgeons, oral surgeons, dentists, hospitals, stocking distributors, healthcare dealers, and other specialists, as well as agents, healthcare purchasing organizations, or buying groups. The company was formerly known as Zimmer Holdings, Inc. and changed its name to Zimmer Biomet Holdings, Inc. in June 2015. Zimmer Biomet Holdings, Inc. was founded in 1927 and is headquartered in Warsaw, Indiana.

Governance aziendale

L'ISS Governance QualityScore di Zimmer Biomet Holdings, Inc. al 1 aprile 2021 è 3. I criteri di valutazione fondamentali sono revisione: 7; Consiglio di Amministrazione: 2; diritti degli azionisti: 5; retribuzione: 5.

Punteggi di corporate governance forniti da Institutional Shareholder Services (ISS). I punteggi indicano il rango decile relativo all’indice o alla regione. Un punteggio di decile pari a 1 indica un governance risk più basso, mentre un punteggio di 10 indica un governance risk più alto.